Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis.

Cheng HD, Stöckmann H, Adamczyk B, McManus CA, Ercan A, Holm IA, Rudd PM, Ackerman ME, Nigrovic PA.

Glycobiology. 2017 Dec 1;27(12):1099-1108. doi: 10.1093/glycob/cwx082.

2.

Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation.

Ercan A, Barnes MG, Hazen M, Tory H, Henderson L, Dedeoglu F, Fuhlbrigge RC, Grom A, Holm IA, Kellogg M, Kim S, Adamczyk B, Rudd PM, Son MB, Sundel RP, Foell D, Glass DN, Thompson SD, Nigrovic PA.

Arthritis Rheum. 2012 Sep;64(9):3025-33. doi: 10.1002/art.34507.

3.

Modulating IgG effector function by Fc glycan engineering.

Li T, DiLillo DJ, Bournazos S, Giddens JP, Ravetch JV, Wang LX.

Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3485-3490. doi: 10.1073/pnas.1702173114. Epub 2017 Mar 13.

4.

Up regulated complement and fc receptors in juvenile idiopathic arthritis and correlation with disease phenotype.

Prokopec KE, Berntson L, Öman A, Kleinau S.

J Clin Immunol. 2012 Jun;32(3):540-50. doi: 10.1007/s10875-012-9657-4. Epub 2012 Feb 11.

PMID:
22328105
5.

Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.

Bondt A, Rombouts Y, Selman MH, Hensbergen PJ, Reiding KR, Hazes JM, Dolhain RJ, Wuhrer M.

Mol Cell Proteomics. 2014 Nov;13(11):3029-39. doi: 10.1074/mcp.M114.039537. Epub 2014 Jul 8.

6.

Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.

de Haan N, Reiding KR, Driessen G, van der Burg M, Wuhrer M.

J Proteome Res. 2016 Jun 3;15(6):1853-61. doi: 10.1021/acs.jproteome.6b00038. Epub 2016 May 19.

PMID:
27161864
7.

Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.

Fotis L, Shaikh N, Baszis KW, Samson CM, Lev-Tzion R, French AR, Tarr PI.

J Rheumatol. 2017 Nov;44(11):1624-1631. doi: 10.3899/jrheum.161589. Epub 2017 Sep 15.

8.

The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions.

Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, Lellouch AC, Rudd PM, Woof JM, Dwek RA.

J Biol Chem. 1998 Jan 23;273(4):2260-72.

9.

Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.

Hills AE, Patel A, Boyd P, James DC.

Biotechnol Bioeng. 2001 Oct 20;75(2):239-51.

PMID:
11536148
10.

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities.

Dekkers G, Treffers L, Plomp R, Bentlage AEH, de Boer M, Koeleman CAM, Lissenberg-Thunnissen SN, Visser R, Brouwer M, Mok JY, Matlung H, van den Berg TK, van Esch WJE, Kuijpers TW, Wouters D, Rispens T, Wuhrer M, Vidarsson G.

Front Immunol. 2017 Aug 2;8:877. doi: 10.3389/fimmu.2017.00877. eCollection 2017.

11.

Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.

Wuhrer M, Stavenhagen K, Koeleman CA, Selman MH, Harper L, Jacobs BC, Savage CO, Jefferis R, Deelder AM, Morgan M.

J Proteome Res. 2015 Apr 3;14(4):1657-65. doi: 10.1021/pr500780a. Epub 2015 Mar 24.

PMID:
25761865
12.

Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.

Wong AH, Fukami Y, Sudo M, Kokubun N, Hamada S, Yuki N.

J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):275-9. doi: 10.1136/jnnp-2014-309964. Epub 2015 Mar 26.

PMID:
25814494
13.

Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.

Šimurina M, de Haan N, Vučković F, Kennedy NA, Štambuk J, Falck D, Trbojević-Akmačić I, Clerc F, Razdorov G, Khon A, Latiano A, D'Incà R, Danese S, Targan S, Landers C, Dubinsky M; Inflammatory Bowel Disease Biomarkers Consortium, McGovern DPB, Annese V, Wuhrer M, Lauc G.

Gastroenterology. 2018 Apr;154(5):1320-1333.e10. doi: 10.1053/j.gastro.2018.01.002. Epub 2018 Jan 6.

PMID:
29309774
14.

Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.

Selman MH, de Jong SE, Soonawala D, Kroon FP, Adegnika AA, Deelder AM, Hokke CH, Yazdanbakhsh M, Wuhrer M.

Mol Cell Proteomics. 2012 Apr;11(4):M111.014563. doi: 10.1074/mcp.M111.014563. Epub 2011 Dec 19.

15.

IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.

Fokkink WJ, Selman MH, Dortland JR, Durmuş B, Kuitwaard K, Huizinga R, van Rijs W, Tio-Gillen AP, van Doorn PA, Deelder AM, Wuhrer M, Jacobs BC.

J Proteome Res. 2014 Mar 7;13(3):1722-30. doi: 10.1021/pr401213z. Epub 2014 Feb 17.

PMID:
24533874
16.

Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis.

Kemna MJ, Plomp R, van Paassen P, Koeleman CAM, Jansen BC, Damoiseaux JGMC, Cohen Tervaert JW, Wuhrer M.

EBioMedicine. 2017 Mar;17:108-118. doi: 10.1016/j.ebiom.2017.01.033. Epub 2017 Jan 28.

17.

Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G.

Einarsdottir HK, Selman MH, Kapur R, Scherjon S, Koeleman CA, Deelder AM, van der Schoot CE, Vidarsson G, Wuhrer M.

Glycoconj J. 2013 Feb;30(2):147-57. doi: 10.1007/s10719-012-9381-6. Epub 2012 May 10.

18.

Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.

Reusch D, Haberger M, Falck D, Peter B, Maier B, Gassner J, Hook M, Wagner K, Bonnington L, Bulau P, Wuhrer M.

MAbs. 2015;7(4):732-42. doi: 10.1080/19420862.2015.1045173.

19.

High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.

Baković MP, Selman MH, Hoffmann M, Rudan I, Campbell H, Deelder AM, Lauc G, Wuhrer M.

J Proteome Res. 2013 Feb 1;12(2):821-31. doi: 10.1021/pr300887z. Epub 2013 Jan 18.

PMID:
23298168
20.

Supplemental Content

Support Center